Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A phase I study of bevacizumab (B) in combination with everolimus (E) and erlotinib (E) in advanced cancer (BEE).
Bullock KE, Petros WP, Younis I, Uronis HE, Morse MA, Blobe GC, Zafar SY, Gockerman JP, Lager JJ, Truax R, Meadows KL, Howard LA, O'Neill MM, Broadwater G, Hurwitz HI, Bendell JC. Bullock KE, et al. Among authors: truax r. Cancer Chemother Pharmacol. 2011 Feb;67(2):465-74. doi: 10.1007/s00280-010-1507-6. Epub 2010 Nov 16. Cancer Chemother Pharmacol. 2011. PMID: 21079958 Free PMC article. Clinical Trial.
A phase I study of UFT/leucovorin, carboplatin, and paclitaxel in combination with external beam radiation therapy for advanced esophageal carcinoma.
Czito BG, Cohen DP, Kelsey CR, Lockhart AC, Bendell JC, Willett CG, Petros WP, D'Amico TA, Truax R, Hurwitz HI. Czito BG, et al. Among authors: truax r. Int J Radiat Oncol Biol Phys. 2008 Mar 15;70(4):1066-72. doi: 10.1016/j.ijrobp.2007.07.2347. Epub 2007 Sep 19. Int J Radiat Oncol Biol Phys. 2008. PMID: 17881149 Clinical Trial.
Phase I and pharmacokinetic study of lonafarnib, SCH 66336, using a 2-week on, 2-week off schedule in patients with advanced solid tumors.
Castaneda C, Meadows KL, Truax R, Morse MA, Kaufmann SH, Petros WP, Zhu Y, Statkevich P, Cutler DL, Hurwitz HI. Castaneda C, et al. Among authors: truax r. Cancer Chemother Pharmacol. 2011 Feb;67(2):455-63. doi: 10.1007/s00280-010-1488-5. Epub 2010 Oct 24. Cancer Chemother Pharmacol. 2011. PMID: 20972873 Clinical Trial.
In vitro anti-proliferative activities of ellagic acid.
Losso JN, Bansode RR, Trappey A 2nd, Bawadi HA, Truax R. Losso JN, et al. Among authors: truax r. J Nutr Biochem. 2004 Nov;15(11):672-8. doi: 10.1016/j.jnutbio.2004.06.004. J Nutr Biochem. 2004. PMID: 15590271
25 results